Skip to content

A review of sevoflurane induction methods in Children

High concentration versus incremental induction of anaesthesia with sevoflurane in children: A study of induction time, complications and cost effectiveness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/12/010773
Enrollment
60
Registered
2017-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA I and ASA II patients

Interventions

None listed

Sponsors

Ameya Ghude
Lead Sponsor
Anila Malde
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA-I and II 2. Either sex 3. Age group 6 months to 8 years 4. Patients undergoing general anaesthesia with supraglottic device 5. duration of surgery from 20 minutes to 90 minutes

Exclusion criteria

Exclusion criteria: 1. Age group 8 years 2. ASA III and above 3. Non-starved patients 4. Difficult airway 5. Active upper or lower respiratory tract infection 6. Craniofacial abnormalities 7. Cardiopulmonary defects 8. Hepatic or renal insufficiency 9. Known seizure disorder 10. Neuromuscular defects 11. Bleeding/clotting abnormality 12. Non-consenting parent

Design outcomes

Primary

MeasureTime frame
1. Induction time by the two induction methods 2. Amount of Sevoflurane used by the two induction methods 3. Side effects of the two induction methodsTimepoint: 1. At the time of loss of eyelash reflex. 2. At the time of successful I gel insertion. 3. 2 minutes after successful I gel insertion

Secondary

MeasureTime frame
MAC achieved during the two induction methodsTimepoint: 1. At the time of loss of eyelash reflex. 2. At the time of successful I gel insertion. 3. 2 minutes after successful I gel insertion

Countries

India

Contacts

Public ContactAmeya Ghude

LTMMC & LTMGH

ameyaghude@gmail.com9594933227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026